Skip to main content
SUDEVCO — Sustainable Development Company

Sector research & intelligence

Research catalogue

Premium investor briefs and competitive landscapes with named forward calls, across SUDEVCO's two lenses — Bioindustry & Bio-based Economy and Health & Nutrition. A small catalogue, carefully maintained, written from inside the industry.

Available

Directory Bioindustry

Global Fermentation CDMO & Pilot Infrastructure Directory

Directory

The definitive map of the global microbial-fermentation toll and CDMO supply base: 41 tollers you can actually hire — 5 purpose-built precision-fermentation plants, 18 established CDMOs and 18 regional & specialist tollers — inside a 59-counterparty register, with 17 deep-dive profiles and a 20-facility global pilot & scale-up shortlist. Every counterparty is indexed on archetype, geography, certification tier, the molecules it runs, third-party-toll status and cost, across food precision fermentation, feed and animal nutrition, agricultural biologics, and industrial proteins and enzymes.

53 pages · Data as of 2026-06-30 View directory →
Full Report Health & Nutrition

Human Milk Oligosaccharides

Competitive & Commercial Landscape

The definitive map of the HMO competitive and commercial landscape: twelve chapters and six appendices, 38+ named exhibits and 100+ public-record citations. Supply read plant-by-plant, the cost stack built bottom-up, the IP cliff as a maintenance-fee schedule with named expiries through 2042, regulatory access named structure by jurisdiction by player, and health evidence graded trial-by-trial.

74 pages · Data as of 2026-05-25 View report →
Investor Brief Health & Nutrition

Human Milk Oligosaccharides

Investor Brief

A 28-page sector note on Human Milk Oligosaccharides at the inflection point: a Chinese cost cohort now at near-parity with Western mature plants, the manufacturing-IP staircase running 2027 to 2035, and value migrating off the flagship 2'-FL into multi-HMO blends. Written from inside the industry, with a named, dated, falsifiable forward call on where the durable Western returns live..

28 pages · Data as of 2026-05-01 View brief →

SUDEVCO Atlas

Ask Atlas and ChatGPT the same question.

One answer is grounded in fact. The other is confidently made up.

Atlas pairs a cross-linked evidence base — every figure traced to a real, dated source — with twenty years on the operating side of these industries. Fact, calibrated by experience.

Biotics · supply side

Strain passports

~400 strains, each resolved to its deposit, human trials, IP family, regulatory standing and owner — so a supplier, strain or licensing target resolves to one identity, not a guess.

Biotics · demand side

The consumer shelf

~8,500 products across 70 retail platforms in 30+ markets — ~3,900 cross-linked to the strain and the evidence behind the claim, read against 12,600 consumer reviews.

Beyond biotics

The wider map

HMOs (40 clinical trials, 17 production sites, the patent landscape), precision-fermentation dairy (26 players), the raw-material transition (54 companies), and a bio-based registry of 400+ companies across 580 sites.

Put Atlas to work on your decision →

We don’t sell access to Atlas — it’s the BI engine behind a bespoke engagement.

Coverage

Two lenses, built out one sector at a time — what is published today, and what is on the research agenda.

Bioindustry & Bio-based Economy

  • Fermentation, CDMO & Toll Infrastructure Published · 1 report →
  • Industrial Enzymes In progress · 2026-Q3
  • Precision Fermentation & Synthetic Biology In progress · 2026-Q3
  • Classic Fermentation Planned · 2027-Q1

Health & Nutrition

  • Specialty Bio-Ingredients Published · 2 reports →
  • Pre/Pro/Postbiotics — Supplements In progress · 2026-Q4
  • Pre/Pro/Postbiotics — Skin Microbiome Planned · 2027-Q1